Disparities and drivers of early age at diagnosis of congestive heart failure in the USA.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 10 2019
Historique:
received: 12 03 2019
revised: 13 05 2019
accepted: 01 06 2019
pubmed: 25 6 2019
medline: 14 7 2020
entrez: 25 6 2019
Statut: ppublish

Résumé

Heart failure (HF) constitutes a major public health problem in the USA due to its high morbidity and mortality. Age at diagnosis of HF would refine burden quantification, budgeting, disease surveillance and assessment of interventions. We set out to determine the median age at diagnosis of HF and drivers of young age at diagnosis among patients 20 years or older in the USA. We utilized NHANES data collected across five survey cycles (2007-2016). Included were individuals aged 20 to 80 years diagnosed of HF with valid entries for age at diagnosis. Differences in age at diagnosis between groups and major drivers for younger age at diagnosis were assessed using linear regression models with p-values <0.05 considered statistically significant. The prevalence of HF in the USA was 2.44% with a median age at diagnosis of 59 years (IQR 47-70). Non-Hispanic (NH) Blacks -4.94 years (95% CI -7.95 to -1.93), individuals living below the poverty line -5.79 years (95% CI -10.36 to -1.01), obese persons -5.63 years (95% CI -8.35 to -2.92), individuals without health insurance -4.31 years (95% CI -7.87 to -0.75) and those without hypertension -3.99 years (95% CI -7.19 to -0.78) were diagnosed at significantly younger ages than their respective counterparts. The median age at diagnosis of HF in the USA is 59 years. NH Blacks, living in poverty, lack of health insurance and obesity are the main drivers of early age at diagnosis of HF in the USA.

Identifiants

pubmed: 31230932
pii: S0167-5273(19)31345-2
doi: 10.1016/j.ijcard.2019.06.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-147

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Chobufo Muchi Ditah (CM)

Interfaith Medical Center, Brooklyn, NY, USA. Electronic address: ditahdivine@gmail.com.

Ebad Rahman (E)

Interfaith Medical Center, Brooklyn, NY, USA.

Valirie Ndip Agbor (VN)

Ibal Sub-divisional Hospital, Oku, Northwest Region, Cameroon; Department of Clinical Research, Health Education and Research Organisation (HERO), Cameroon.

Joyce Bei Foryoung (JB)

Ministry of Public Health, Cameroon.

Moazzam Shahzad (M)

Interfaith Medical Center, Brooklyn, NY, USA.

Birendra Amgai (B)

Interfaith Medical Center, Brooklyn, NY, USA.

Paritosh Kafle (P)

Interfaith Medical Center, Brooklyn, NY, USA.

Saikiran Jonnadula (S)

Interfaith Medical Center, Brooklyn, NY, USA.

Tonga Karngong Nfor (TK)

Aurora's St. Luke's Medical Center, USA.

Alix Dufresne (A)

Interfaith Medical Center, Brooklyn, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH